CAPPED BONUSZERTIFIKAT - MERCK & CO. Share Price

Certificat

DE000PC67MY3

Real-time Bid/Ask 07:48:21 07/06/2024 pm IST
109.25 EUR / 109.27 EUR +0.59% Intraday chart for CAPPED BONUSZERTIFIKAT - MERCK & CO.
Current month-0.02%
1 month-0.36%
Date Price Change
07/24/07 108.5 -0.11%
06/24/06 108.6 -0.02%
05/24/05 108.6 +0.25%
04/24/04 108.4 -0.24%
03/24/03 108.6 -0.01%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 01:16 pm IST

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC67MY
ISINDE000PC67MY3
Date issued 25/03/2024
Strike 120 $
Maturity 20/09/2024 (105 Days)
Parity 1 : 1
Emission price 105.8
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 109.6
Lowest since issue 106.8
Spread 0.02
Spread %0.02%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.5 USD
Average target price
142.7 USD
Spread / Average Target
+9.32%
Consensus